Stay updated with breaking news from Robertb Ford. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Abbott Laboratories exceeds expectations with Q4 sales of $10.24B, showcasing resilience despite softer demand for COVID-19 testing. CEO anticipates continued growth in 2024.
Less than two years after a headline-grabbing shutdown of a baby formula plant in Michigan, Abbott Laboratories has "reclaimed its previous market-leading position."
ABBOTT PARK, Ill., Dec. 18, 2023 /PRNewswire/ -- Abbott will present at the 42nd annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 9, 2024. Robert B. Ford, chairman and chief executive...
Sales of $10.1 billion driven by strong underlying base business performance Reported sales decreased 2.6 percent due to anticipated decline in COVID-19 testing-related sales versus prior...
The main drivers of Abbott’s baseline sales growth during the quarter was its nutrition segment, which was up 15.5% compared to Q3 2022.